secwatch.observer — SEC 8-K summary
======================================

Issuer:     Celularity Inc (CELU)
CIK:        0001752828
Form:       8-K
Filed at:   2024-08-28T23:59:59+00:00
Accession:  0001493152-24-034216
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Celularity appoints Richard J. Berman to Board; reduces board from 7 to 6
-------------------------------------------------------------------------

- Richard J. Berman appointed as Class II director, effective Aug 27, 2024, to fill vacancy left by Robin L. Smith.
- Berman received an option to purchase 118,111 shares at $3.01/share, vesting in three equal annual installments.
- Board reduced from seven to six directors following Marc Mazur's departure; Class III reduced from two to one.
- Berman brings over 40 years of VC and M&A experience; served on boards of six companies over $1B market value.
- He was appointed to the Audit Committee; qualifies as independent under Nasdaq rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1752828/000149315224034216/0001493152-24-034216-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1752828/000149315224034216/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-034216

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer